New Treatment for EoE Shows Lasting Benefits in Major Clinical Trial
A Phase 3 trial found Tezspire significantly reduced esophageal inflammation and swallowing difficulties in patients with eosinophilic esophagitis. The post New Treatment for EoE Shows Lasting Benefits in Major Clinical Trial appeared first on SnackSafely.com .
